Australia markets close in 4 hours 12 minutes

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.9100-0.1700 (-5.52%)
At close: 04:00PM EDT
2.9999 +0.09 (+3.09%)
After hours: 07:58PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts15151717
Avg. Estimate-0.35-0.36-1.52-1.57
Low estimate-0.39-0.45-2.06-2.16
High estimate-0.28-0.26-1.19-1.21
Year ago EPS-0.53-0.37-2.09-1.52
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts11121515
Avg. Estimate20k10k50k4.1M
Low estimateN/AN/AN/AN/A
High estimate50k50k170k60.97M
Year ago sales44kN/A95k50k
Sales growth (year/est)-54.50%N/A-47.40%8,100.00%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.59-0.52-0.45-0.41
Actual EPS-0.53-0.37-0.51-0.38
Difference0.060.15-0.060.03
Surprise %10.20%28.80%-13.30%7.30%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.35-0.36-1.52-1.57
7 days ago-0.35-0.36-1.52-1.57
30 days ago-0.35-0.36-1.49-1.54
60 days ago-0.35-0.36-1.51-1.56
90 days ago-0.4-0.39-1.65-1.57
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesALLOIndustrySector(s)S&P 500
Current qtr.34.00%N/AN/AN/A
Next qtr.2.70%N/AN/AN/A
Current year27.30%N/AN/AN/A
Next year-3.30%N/AN/AN/A
Next 5 years (per annum)1.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A